BDBM696709 (R)-N-(2-cyclopropyl-5-(3- methyl-4-(oxetan-3- yl)piperazin-1-yl)pyridin-3-yl)- 6-(1-(2,2,2-trifluoroethyl)-1H- pyrazol-4-yl)picolinamide::US20240308980, Ex-1.74

SMILES C[C@@H]1CN(CCN1C1COC1)c1cnc(C2CC2)c(NC(=O)c2cccc(n2)-c2cnn(CC(F)(F)F)c2)c1

InChI Key InChIKey=MLQSBVVCTGINLP-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 696709   

TargetLeucine-rich repeat serine/threonine-protein kinase 2 [G2019S](Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM696709((R)-N-(2-cyclopropyl-5-(3- methyl-4-(oxetan-3- yl)...)
Affinity DataIC50: 1.92E+3nMAssay Description:Compound potency against LRRK2 kinase activity was determined using LanthaScreen technology from Life Technologies Corporation (Carlsbad, CA) using a...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
1/16/2025
Entry Details
US Patent